Effect of plasmalogen -containing food on cognitive function in patients with Alzheimer disease - a single- blind trial -

Effect of plasmalogen -containing food on cognitive function in patients with Alzheimer disease - a single- blind trial - - Alzheimer disease and plasmalogen

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009898

Enrollment

Registered

2013-01-29

Start date

2013-01-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer disease

Interventions

To administer the test food (the drink containing 0.5mg of plasmalogen) twice a day for 6 months and observe the changes of MMSE and other medical indices To administer the test food (the drink contai

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Male and female who are 60 years old or above 2.Slight to moderate Alzheimer disease patients 3.Those who have received sufficient explanations on the trial and given an

Exclusion criteria

Exclusion criteria: 1.Those who have bird allergy 2.Those who were judged unqualified by the responsible doctor

Design outcomes

Primary

Measure	Time frame
Cognitive function test (MMSE)	—

Secondary

Measure	Time frame
Levels of plasmalogen in the red cell Blood chemical examination Blood pressure	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026